BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 77224)

  • 1. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
    Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
    Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
    [No Abstract]   [Full Text] [Related]  

  • 2. Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.
    Bubeník J; Indrová M; Nemecková S; Malkovský M; Von Broen B; Pálek V; Anderlíková J
    Int J Cancer; 1978 Mar; 21(3):348-55. PubMed ID: 75857
    [No Abstract]   [Full Text] [Related]  

  • 3. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunoreactivity of tumor-bearing mice with myelin basic protein and related peptides.
    Klemm SA; Smith R; Halliday WJ
    Cell Immunol; 1986 Jul; 100(2):434-42. PubMed ID: 2428511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
    Bosslet K; Schirrmacher V; Shantz G
    Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular sensitization to fetal antigens during chemical carcinogenesis].
    Pasternak G; Schlott B; Gryschek G; von Broen B; Albrecht S; Reinhöfer J
    Biomed Biochim Acta; 1983; 42(6):777-84. PubMed ID: 6639648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostasis against self-antigens.
    De Giorgi L; Matossian-Rogers A; Festenstein H
    Clin Exp Immunol; 1978 Feb; 31(2):209-17. PubMed ID: 77201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F; Cater DB; Mehrishi JN
    Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 14. Ability of delayed-type hypersensitivity reactions to distinguish tumor-associated antigens and histocompatibility antigens in soluble extracts from murine fibrosarcomas.
    Kon ND; Forbes JT; Klein PA
    Int J Cancer; 1976 May; 17(5):613-20. PubMed ID: 57934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic lymphocyte stimulation to tumor--specific antigens after immunization with modified tumor cells.
    Enker WE; Jacobitz JL
    Surg Forum; 1976; 27(62):154-7. PubMed ID: 1019838
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of immune paralysis at large tumor volumes.
    Pardridge DH; Wang BS; Mannick JA; Deckers PJ
    Surg Forum; 1975; 26():118-20. PubMed ID: 56046
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two functionally distinct cross-reactive tumor antigens associated with ultraviolet light and chemically induced tumors.
    Roberts LK; Lynch DH; Daynes RA
    Transplantation; 1982 Apr; 33(4):352-60. PubMed ID: 6176053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
    Schlott B; Gryschek G; Albrecht S; Pasternak G
    Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.